LIMN

Liminatus Pharma, Inc. Class A Common Stock (LIMN) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

No Form 4 insider filings for LIMN were recorded at the SEC in the past 30 days^[1].